Funded Startups in Cambridge, Massachusetts

Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.

Commonwealth Fusion Systems designs and develops commercial fusion energy systems to produce clean energy.

Mediar is a pre-clinical stage biotechnology company developing therapeutics for the treatment of fibrosis.

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

Stylus Medicine is on a quest to create disease-treating agents for the next generation based on the groundbreaking work of its founders.

Software development technology, cloud-native, serverless computing

Qureight is an imaging analytics company.

Hopara accelerates the discovery of game-changing insights.

Abselion is the biological sensor for rapid and cost-effective detection of biological substances.

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.

Intelligent bioprocess platform

Fount Bio is a life science company that applies proprietary advances in glycopolymer research for skin health.

Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.

Zag Bio is a biotechnology company that designs thymus-targeting bifunctional antibody medicines to treat and prevent autoimmune diseases.

Marengo Therapeutics is seeking professionals who are motivated to make a positive difference in patients’ lives.

HyperLight is a producer of thin-film lithium niobate photonic integrated circuit solutions.

Cyclops.io is a new operating system for team collaboration.

Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.

Leveraging AI to transform information into insights

STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy in a more efficient and practical manner.

Copernic Catalysts develops sustainable chemical catalysts and processes.

Droplet Biosciences can offer earlier and more accurate cancer diagnosis by using lymphatic fluid.

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.

Pascal is a technological company that is developing a new class of solid refrigerants with the potential to alter HVAC sector.

Coolant helps people measure how much carbon is stored in their trees with drones and computer vision.